National Center for Complementary & Alternative Medicine; Notice of Closed Meeting, 1220 [E9-264]
Download as PDF
sroberts on PROD1PC70 with NOTICES
1220
Federal Register / Vol. 74, No. 7 / Monday, January 12, 2009 / Notices
8131, Bethesda, MD 20892, 301–594–1402,
lopacw@mail.nih.gov.
Name of Committee: National Cancer
Institute Initial Review Group, Subcommittee
G-Education.
Date: February 17–18, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington DC/Rockville,
1750 Rockville Pike, Rockville, MD 20852.
Contact Person: Jeannette F Korczak, PhD,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Blvd., Room
8115, Bethesda, MD 20892, 301–496–9767,
korczakj@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Prevention
Control and Population Sciences.
Date: February 18–19, 2009.
Time: 8 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marriott Bethesda North Hotel &
Conference Center, 5700 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Peter J. Wirth, PhD,
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Boulevard, Room 8131,
Bethesda, MD 20892–8328, 301–496–7565,
pw2q@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Education
Meeting (K05 & R25).
Date: February 18, 2009.
Time: 10 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Lynn M Amende, PhD,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Boulevard,
Room 8105, Bethesda, MD 20892–8328, 301–
451–4759, amendel@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Health
Information Technology in Cancer Care.
Date: March 3, 2009.
Time: 8:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications
Place: National Institutes of Health, 6116
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call)
Contact Person: Rhonda J. Moore, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Boulevard, Room 7151,
Bethesda, MD 20892–8329, 301–451–9385,
moorerh@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Small
Grants for Behavioral Research in Cancer
Control.
Date: March 12–13, 2009.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Nov<24>2008
20:34 Jan 09, 2009
Jkt 217001
Place: Bethesda Marriott—Pooks Hill, 5151
Pooks Hill Road, Bethesda, MD 20814.
Contact Person: Rhonda J. Moore, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Boulevard, Room 7151,
Bethesda, MD 20892–8329, 301–451–9385,
moorerh@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Smokeless
Tobacco Use Cessation.
Date: March 25, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Sherwood Githens, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 6116
Executive Blvd., Room 8053, Bethesda, MD
20892, 301/435–1822,
GITHENSS@MAIL.NIH.GOV.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Cancer
Disparities Research Partnership Program.
Date: March 26, 2009.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications
Place: Bethesda Marriott—Pooks Hill, 5151
Pooks Hill Road, Bethesda, MD 20814.
Contact Person: Rhonda J. Moore, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Boulevard, Room 7151,
Bethesda, MD 20892–8329, 301–451–9385,
moorerh@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: January 5, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–266 Filed 1–9–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Alternative Medicine; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel; Clinical Research in
CAM.
Date: February 23–24, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Laurie Friedman Donze,
PhD, Scientific Review Officer, Office of
Scientific Review, National Center for
Complementary and Alternative Medicine,
NIH, 6707 Democracy Blvd., Suite 401,
Bethesda, MD 20892, 301–402–1030,
donzel@mail.nih.gov.
Dated: January 5, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–264 Filed 1–9–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of meetings of the
National Advisory Council for Human
Genome Research.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
E:\FR\FM\12JAN1.SGM
12JAN1
Agencies
[Federal Register Volume 74, Number 7 (Monday, January 12, 2009)]
[Notices]
[Page 1220]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-264]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Complementary & Alternative Medicine; Notice
of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Complementary and
Alternative Medicine Special Emphasis Panel; Clinical Research in
CAM.
Date: February 23-24, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road, NW., Washington, DC 20015.
Contact Person: Laurie Friedman Donze, PhD, Scientific Review
Officer, Office of Scientific Review, National Center for
Complementary and Alternative Medicine, NIH, 6707 Democracy Blvd.,
Suite 401, Bethesda, MD 20892, 301-402-1030, donzel@mail.nih.gov.
Dated: January 5, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-264 Filed 1-9-09; 8:45 am]
BILLING CODE 4140-01-P